No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:147163200-147178800 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr6:147163400-147178800 |
Weak transcription |
Pancreatic Islets |
Pancreatic Islet
|
3 |
chr6:147171200-147173800 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
4 |
chr6:147171400-147173400 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
5 |
chr6:147171400-147173600 |
Enhancers |
NH-A |
brain
|
6 |
chr6:147171400-147173600 |
Enhancers |
NHDF-Ad |
bronchial
|
7 |
chr6:147171600-147173800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
8 |
chr6:147171800-147172800 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
9 |
chr6:147171800-147173800 |
Enhancers |
NHEK |
skin
|
10 |
chr6:147172000-147173000 |
Weak transcription |
K562 |
blood
|
11 |
chr6:147172000-147173200 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
12 |
chr6:147172000-147178400 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
13 |
chr6:147172200-147173800 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
14 |
chr6:147172200-147178800 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
15 |
chr6:147172400-147173800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
16 |
chr6:147172400-147176800 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
17 |
chr6:147172600-147172800 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
18 |
chr6:147172600-147173400 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
19 |
chr6:147172600-147173400 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
20 |
chr6:147172600-147173400 |
Enhancers |
Osteobl |
bone
|
21 |
chr6:147172600-147173600 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|